相关实验视频

Updated: Jul 4, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

鉴定静脉血栓栓塞的诊断特征和免疫微环境亚型

Shuai Niu¹, Ruoyu Dong², Guangwei Jiang²

¹Department of Vascular Surgery, the Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China; Department of Vascular Surgery, Hebei General Hospital, Shijiazhuang, Hebei, China.

|June 30, 2024

概括

这项研究确定了与静脉血栓栓塞 (VTE) 病原发生相关的关键免疫基因,揭示了不同的患者亚型和预测模型. 这些发现可能会改善VTE预防,诊断和个性化治疗策略.

科学领域:

免疫学免疫学免疫学
遗传学遗传学是一种遗传学.
计算生物学计算生物学

背景情况:

免疫系统与静脉血栓栓塞 (VTE) 病原体之间的复杂关系是公认的,但尚未完全理解.
识别特定的免疫特征对于推进VTE研究和临床管理至关重要.

研究的目的:

用可解释的机器学习在VTE中识别与免疫微环境相关的签名和亚型.
开发VTE风险的预测模型,并探索潜在的治疗点.

主要方法:

对VTE患者免疫微环境变化的分析.
使用机器学习识别关键的免疫细胞和基因 (PTPN6,ITGB2,CR2,FPR2,MMP9,ISG15).
开发和验证VTE风险预测模型 (XGBoost).
使用qPCR对诊断生物标志物 (CR2,FPR2) 的验证.

主要成果:

在VTE中发现了8个关键免疫细胞和6个与免疫相关的基因.
冠状动脉瘤患者被分为两个亚型,具有不同的免疫和代谢特征.
在预测VTE风险方面,XGBoost模型表现出卓越的性能.
CR2和FPR2作为VTE的潜在诊断生物标志物具有很高的准确性.

结论:

已发现的与微环境相关的免疫基因 (PTPN6,ITGB2,CR2,FPR2,MMP9,ISG15) 在静脉突发症的发病过程中至关重要.
开发的VTE风险预测模型和确定的亚型为改善临床预防,诊断和个性化治疗策略提供了潜力.

关键词:

诊断诊断诊断诊断诊断免疫细胞是免疫细胞.免疫环境亚型免疫环境亚型机器学习机器学习静脉血栓塞栓症是一种静脉血栓塞栓症.

更多相关视频

Isolation and Characterization of Microvesicles from Peripheral Blood

Isolation and Characterization of Microvesicles from Peripheral Blood

Published on: January 6, 2017

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

相关概念视频

Venous Thrombosis I: Introduction

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...